The global market for Single Organ-on-a-Chip Models was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Single Organ-on-a-Chip Models is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Single Organ-on-a-Chip Models is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Single Organ-on-a-Chip Models in Pharmaceutical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Single Organ-on-a-Chip Models include Emulate, Mimetas, CN Bio Innovations, Hesperos, AxoSim, Elvesys, InSphero, Beijing Abace Biotechnology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Single Organ-on-a-Chip Models, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single Organ-on-a-Chip Models.
The Single Organ-on-a-Chip Models market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Single Organ-on-a-Chip Models market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single Organ-on-a-Chip Models companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Emulate
Mimetas
CN Bio Innovations
Hesperos
AxoSim
Elvesys
InSphero
Beijing Abace Biotechnology
Segment by Type
Kidney-on-a-chip Model
Liver-on-a-chip Model
Brain-on-a-chip Model
Heart-on-a-chip Model
Others
Segment by Application
Pharmaceutical
Research Institute
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Single Organ-on-a-Chip Models company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Single Organ-on-a-Chip Models Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Kidney-on-a-chip Model
1.2.3 Liver-on-a-chip Model
1.2.4 Brain-on-a-chip Model
1.2.5 Heart-on-a-chip Model
1.2.6 Others
1.3 Market by Application
1.3.1 Global Single Organ-on-a-Chip Models Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Research Institute
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Single Organ-on-a-Chip Models Market Perspective (2020-2031)
2.2 Global Single Organ-on-a-Chip Models Growth Trends by Region
2.2.1 Global Single Organ-on-a-Chip Models Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Single Organ-on-a-Chip Models Historic Market Size by Region (2020-2025)
2.2.3 Single Organ-on-a-Chip Models Forecasted Market Size by Region (2026-2031)
2.3 Single Organ-on-a-Chip Models Market Dynamics
2.3.1 Single Organ-on-a-Chip Models Industry Trends
2.3.2 Single Organ-on-a-Chip Models Market Drivers
2.3.3 Single Organ-on-a-Chip Models Market Challenges
2.3.4 Single Organ-on-a-Chip Models Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single Organ-on-a-Chip Models Players by Revenue
3.1.1 Global Top Single Organ-on-a-Chip Models Players by Revenue (2020-2025)
3.1.2 Global Single Organ-on-a-Chip Models Revenue Market Share by Players (2020-2025)
3.2 Global Single Organ-on-a-Chip Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Single Organ-on-a-Chip Models Revenue
3.4 Global Single Organ-on-a-Chip Models Market Concentration Ratio
3.4.1 Global Single Organ-on-a-Chip Models Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single Organ-on-a-Chip Models Revenue in 2024
3.5 Global Key Players of Single Organ-on-a-Chip Models Head office and Area Served
3.6 Global Key Players of Single Organ-on-a-Chip Models, Product and Application
3.7 Global Key Players of Single Organ-on-a-Chip Models, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Single Organ-on-a-Chip Models Breakdown Data by Type
4.1 Global Single Organ-on-a-Chip Models Historic Market Size by Type (2020-2025)
4.2 Global Single Organ-on-a-Chip Models Forecasted Market Size by Type (2026-2031)
5 Single Organ-on-a-Chip Models Breakdown Data by Application
5.1 Global Single Organ-on-a-Chip Models Historic Market Size by Application (2020-2025)
5.2 Global Single Organ-on-a-Chip Models Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Single Organ-on-a-Chip Models Market Size (2020-2031)
6.2 North America Single Organ-on-a-Chip Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Single Organ-on-a-Chip Models Market Size by Country (2020-2025)
6.4 North America Single Organ-on-a-Chip Models Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Single Organ-on-a-Chip Models Market Size (2020-2031)
7.2 Europe Single Organ-on-a-Chip Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Single Organ-on-a-Chip Models Market Size by Country (2020-2025)
7.4 Europe Single Organ-on-a-Chip Models Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Single Organ-on-a-Chip Models Market Size (2020-2031)
8.2 Asia-Pacific Single Organ-on-a-Chip Models Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Single Organ-on-a-Chip Models Market Size by Region (2020-2025)
8.4 Asia-Pacific Single Organ-on-a-Chip Models Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Single Organ-on-a-Chip Models Market Size (2020-2031)
9.2 Latin America Single Organ-on-a-Chip Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Single Organ-on-a-Chip Models Market Size by Country (2020-2025)
9.4 Latin America Single Organ-on-a-Chip Models Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single Organ-on-a-Chip Models Market Size (2020-2031)
10.2 Middle East & Africa Single Organ-on-a-Chip Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Single Organ-on-a-Chip Models Market Size by Country (2020-2025)
10.4 Middle East & Africa Single Organ-on-a-Chip Models Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emulate
11.1.1 Emulate Company Details
11.1.2 Emulate Business Overview
11.1.3 Emulate Single Organ-on-a-Chip Models Introduction
11.1.4 Emulate Revenue in Single Organ-on-a-Chip Models Business (2020-2025)
11.1.5 Emulate Recent Development
11.2 Mimetas
11.2.1 Mimetas Company Details
11.2.2 Mimetas Business Overview
11.2.3 Mimetas Single Organ-on-a-Chip Models Introduction
11.2.4 Mimetas Revenue in Single Organ-on-a-Chip Models Business (2020-2025)
11.2.5 Mimetas Recent Development
11.3 CN Bio Innovations
11.3.1 CN Bio Innovations Company Details
11.3.2 CN Bio Innovations Business Overview
11.3.3 CN Bio Innovations Single Organ-on-a-Chip Models Introduction
11.3.4 CN Bio Innovations Revenue in Single Organ-on-a-Chip Models Business (2020-2025)
11.3.5 CN Bio Innovations Recent Development
11.4 Hesperos
11.4.1 Hesperos Company Details
11.4.2 Hesperos Business Overview
11.4.3 Hesperos Single Organ-on-a-Chip Models Introduction
11.4.4 Hesperos Revenue in Single Organ-on-a-Chip Models Business (2020-2025)
11.4.5 Hesperos Recent Development
11.5 AxoSim
11.5.1 AxoSim Company Details
11.5.2 AxoSim Business Overview
11.5.3 AxoSim Single Organ-on-a-Chip Models Introduction
11.5.4 AxoSim Revenue in Single Organ-on-a-Chip Models Business (2020-2025)
11.5.5 AxoSim Recent Development
11.6 Elvesys
11.6.1 Elvesys Company Details
11.6.2 Elvesys Business Overview
11.6.3 Elvesys Single Organ-on-a-Chip Models Introduction
11.6.4 Elvesys Revenue in Single Organ-on-a-Chip Models Business (2020-2025)
11.6.5 Elvesys Recent Development
11.7 InSphero
11.7.1 InSphero Company Details
11.7.2 InSphero Business Overview
11.7.3 InSphero Single Organ-on-a-Chip Models Introduction
11.7.4 InSphero Revenue in Single Organ-on-a-Chip Models Business (2020-2025)
11.7.5 InSphero Recent Development
11.8 Beijing Abace Biotechnology
11.8.1 Beijing Abace Biotechnology Company Details
11.8.2 Beijing Abace Biotechnology Business Overview
11.8.3 Beijing Abace Biotechnology Single Organ-on-a-Chip Models Introduction
11.8.4 Beijing Abace Biotechnology Revenue in Single Organ-on-a-Chip Models Business (2020-2025)
11.8.5 Beijing Abace Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Emulate
Mimetas
CN Bio Innovations
Hesperos
AxoSim
Elvesys
InSphero
Beijing Abace Biotechnology
听
听
*If Applicable.
